By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS








Company News
Boehringer Ingelheim Release: New Data Reveal High Rates Of Stroke History In Asymptomatic Atrial Fibrillation Patients 6/21/2017 6:38:35 AM
Boehringer Ingelheim Presents Phase III Results Demonstrating Clinical Equivalence Of Adalimumab Biosimilar Candidate To HUMIRA 6/14/2017 8:33:01 AM
Boehringer Ingelheim And Eli Lilly (LLY) Diabetes Alliance To Present 33 Abstracts At The American Diabetes Association’s 77th Scientific Sessions 6/6/2017 3:38:18 PM
Boehringer Ingelheim And Lilly Diabetes Alliance To Present 33 Abstracts At The American Diabetes Association’s 77th Scientific Sessions 6/6/2017 12:54:22 PM
Novatek International Selected As Partner For Automation Of Boehringer Ingelheim's Global Environmental Monitoring Program 6/6/2017 10:48:18 AM
Boehringer Ingelheim Release: Encouraging Phase II Survival Data For Oral Nintedanib In Malignant Pleural Mesothelioma Presented At ASCO 2017 6/5/2017 6:53:44 AM
Boehringer Ingelheim Release: IPF Patients Treated With Ofev (Nintedanib) Versus Placebo Were Twice As Likely To Have Improved Or Stable Lung Function 5/24/2017 7:45:49 AM
Boehringer Ingelheim Release: IPF Patients Treated With OFEV (Nintedanib) Versus Placebo Were Twice As Likely To Have Improved Or Stable Lung Function 5/24/2017 7:20:57 AM
Boehringer Ingelheim Release: American Thoracic Society 2017 Spiriva Respimat Improves Breathing For People With Asthma Regardless Of BMI Or Allergic Status 5/23/2017 9:51:11 AM
Boehringer Ingelheim Strengthens Early Science Portfolio Through Comprehensive Multifaceted Partnership With Peking University 5/16/2017 8:16:41 AM
12345678910...
//-->